Stock Futures Edge Higher Amid Economic Data and Geopolitical Concerns
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 1 hour ago
0mins
Source: seekingalpha
- Abivax Stock Surge: Abivax (ABVX) shares soared 27% after reporting positive Phase 3 results for obefazimod in refractory ulcerative colitis patients, demonstrating significant clinical benefits and reinforcing the drug's long-term safety profile, supporting its planned U.S. NDA submission in Q4 2026.
- AeroVironment Record Performance: AeroVironment (AVAV) shares jumped 20% following its FQ4 results that exceeded Wall Street estimates, with revenue more than doubling to $641.6 million (+133% Y/Y) and adjusted EPS of $1.84, reflecting strong demand and contributions from its BlueHalo acquisition.
- Nuvectis Pharma Stock Decline: Nuvectis Pharma (NVCT) shares fell 16% after pricing a public offering of 5 million shares at $20 each, expecting to raise $100 million in gross proceeds, which will be used to advance its NXP100, NXP200, and NXP900 programs.
- Mama's Creations Stock Drop: Mama's Creations (MAMA) shares tumbled 13% after pricing a public offering of 5.56 million shares at $18 each, anticipating approximately $100 million in gross proceeds, which will be allocated for working capital, general corporate purposes, and potential acquisitions.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy AVAV?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on AVAV
Wall Street analysts forecast AVAV stock price to rise
13 Analyst Rating
13 Buy
0 Hold
0 Sell
Strong Buy
Current: 137.950
Low
315.00
Averages
390.75
High
450.00
Current: 137.950
Low
315.00
Averages
390.75
High
450.00
About AVAV
AeroVironment, Inc. is a defense technology provider delivering integrated capabilities across air, land, sea, space, and cyber. The Company develops and deploys autonomous systems, uncrewed aircraft systems (UAS), precision strike systems, counter-UAS (C-UAS) technologies, space-based platforms, directed energy systems, and cyber and electronic warfare capabilities. Its segments include Autonomous Systems (AxS) and Space, Cyber, and Directed Energy (SCDE). The AxS segment focuses on the design, development, production, delivery, and support of intelligent, multi-domain robotic systems, including UAS, uncrewed underwater vehicles and ground robot systems. It primarily serves organizations within or supplying the U.S. Department of Defense (DoD), other federal agencies, and international allied governments. The SCDE segment focuses on advanced technologies in the space domain providing space-based and ground-based platforms, cyber capabilities, and directed energy systems.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Earnings Beat: AeroVironment reported Q4 earnings of $1.84 per share, surpassing analyst expectations of $1.46, indicating a significant improvement in profitability that is likely to drive stock price higher.
- Significant Revenue Growth: The company achieved total revenue of $642 million, more than doubling the analyst estimate of $559 million, demonstrating strong demand in the drone market and an expansion of market share.
- Growing Funded Backlog: AeroVironment's funded backlog reached $1.2 billion, up 65% year-over-year, although only slightly above the $1.1 billion from the previous quarter, reflecting stability in future orders.
- Strong Performance in Autonomous Systems: Revenue from autonomous systems was $492 million, significantly exceeding the market expectation of $402 million, showcasing the company's competitive edge and robust demand in this sector.
See More
- Abivax Stock Surge: Abivax (ABVX) shares soared 27% after reporting positive Phase 3 results for obefazimod in refractory ulcerative colitis patients, demonstrating significant clinical benefits and reinforcing the drug's long-term safety profile, supporting its planned U.S. NDA submission in Q4 2026.
- AeroVironment Record Performance: AeroVironment (AVAV) shares jumped 20% following its FQ4 results that exceeded Wall Street estimates, with revenue more than doubling to $641.6 million (+133% Y/Y) and adjusted EPS of $1.84, reflecting strong demand and contributions from its BlueHalo acquisition.
- Nuvectis Pharma Stock Decline: Nuvectis Pharma (NVCT) shares fell 16% after pricing a public offering of 5 million shares at $20 each, expecting to raise $100 million in gross proceeds, which will be used to advance its NXP100, NXP200, and NXP900 programs.
- Mama's Creations Stock Drop: Mama's Creations (MAMA) shares tumbled 13% after pricing a public offering of 5.56 million shares at $18 each, anticipating approximately $100 million in gross proceeds, which will be allocated for working capital, general corporate purposes, and potential acquisitions.
See More
- Market Stability: A tentative truce between the U.S. and Iran has led to a stabilization of global markets, with anticipated diplomatic talks in Doha expected to further influence market sentiment, although analysts remain cautious about future trends.
- S&P 500 Target Raised: RBC Capital Markets has raised its year-end S&P 500 target to 8,150 based on stronger earnings expectations, while cautioning investors to prepare for volatility rather than a smooth rally.
- Tesla's New Testing: Tesla has begun engineering tests for its autonomous Cybercab in Austin, which features no steering wheel or pedals; despite Cantor Fitzgerald warning that Q2 deliveries might miss estimates, its AI and autonomous driving initiatives are seen as long-term value drivers.
- Economic Data Focus: Investors will be tracking the upcoming release of the Case-Shiller and FHFA House Price Index, Chicago PMI, and Consumer Confidence Index, along with the JOLTS job openings report, which is expected to provide fresh clues on labor demand and influence Federal Reserve policy decisions.
See More
- Impressive Financial Performance: AeroVironment's Q4 fiscal 2026 results revealed a revenue surge to $641.6 million from $275 million in 2025, with product sales nearing $499 million and contract services exceeding $142.7 million, showcasing robust growth in the drone and defense systems sector.
- Significant Profit Increase: The company reported a net income of over $63 million, a substantial rise from last year's under $17 million, while non-GAAP earnings per share increased from $1.61 to $1.84, significantly surpassing analyst expectations and indicating improved profitability.
- Strong Backlog Growth: As of the end of April, AeroVironment's backlog ballooned to $1.2 billion from under $727 million in 2025, primarily driven by stable orders from the U.S. Army, which underscores the sustainability of future revenues and strong market demand.
- Optimistic Future Guidance: The company forecasts fiscal 2027 revenues between $2.13 billion and $2.23 billion, with adjusted net income projected at $3.02 to $3.34 per share, reflecting confidence in future growth despite a potential slowdown compared to fiscal 2026, while still highlighting market potential and expansion capabilities.
See More
- Impressive Financial Performance: AeroVironment's Q4 fiscal 2026 results revealed a revenue surge from $275 million in 2025 to $641.6 million, with product sales nearing $499 million and contract services quadrupling, showcasing robust growth in the drone and defense systems sector.
- Significant Profit Increase: The company reported over $63 million in net income, a substantial rise from under $17 million a year ago, with non-GAAP earnings per share climbing from $1.61 to $1.84, significantly exceeding analyst expectations of $1.48, reflecting enhanced profitability.
- Strong Backlog Growth: As of the end of April, AeroVironment's backlog reached $1.2 billion, up from $727 million in 2025, primarily driven by stable orders from the U.S. Army, indicating a solid revenue foundation for the future.
- Optimistic Future Guidance: Management forecasts fiscal 2027 revenue between $2.13 billion and $2.23 billion, with adjusted net income projected at $3.02 to $3.34 per share, suggesting that strategic investments in production capacity and international sales will drive continued growth.
See More
- Contract Demand Outlook: CEO Wahid Nawabi indicated that AeroVironment expects strong contract demand over the next 12 to 24 months, supported by expanding defense budgets and a $1.2 billion funded backlog, highlighting the company's market potential in drones and directed-energy weapons.
- Autonomous Systems Drive Growth: Autonomous Systems accounted for 76% of Q4 revenue, with the company securing new U.S. Army orders for the VAPOR 55 CLE helicopter and P550 drone, demonstrating its strong performance and technological advantage in the defense market.
- Laser Weapons Market Potential: Nawabi emphasized the growing interest in the LOCUST laser weapon system, which successfully intercepted drones during Navy testing and costs under $10 per shot, positioning it as a potential growth driver that could shift the cost advantage between offensive and defensive systems.
- Strong Financial Performance: AeroVironment reported Q4 earnings of $1.84 per share, exceeding analysts' expectations of $1.47, with revenue soaring 133% year-on-year to $641.6 million, showcasing the company's robust growth momentum in a competitive market.
See More










